##gff-version 3 P10914 UniProtKB Chain 1 325 . . . ID=PRO_0000154545;Note=Interferon regulatory factor 1 P10914 UniProtKB DNA binding 5 113 . . . Note=IRF tryptophan pentad repeat;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00840 P10914 UniProtKB Region 92 165 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite P10914 UniProtKB Compositional bias 116 143 . . . Note=Basic and acidic residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite P10914 UniProtKB Compositional bias 144 162 . . . Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite P10914 UniProtKB Modified residue 78 78 . . . Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22367195;Dbxref=PMID:22367195 P10914 UniProtKB Cross-link 275 275 . . . Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) P10914 UniProtKB Cross-link 299 299 . . . Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) P10914 UniProtKB Natural variant 8 8 . . . ID=VAR_065134;Note=In GASC%3B somatic mutation%3B produces a protein with markedly reduced transcriptional activity but unaltered DNA-binding activity. M->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9679752;Dbxref=dbSNP:rs121912469,PMID:9679752 P10914 UniProtKB Natural variant 11 11 . . . ID=VAR_065135;Note=In GASC%3B the mutation abolishes DNA binding and transactivating activities. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10395927;Dbxref=dbSNP:rs121912470,PMID:10395927 P10914 UniProtKB Mutagenesis 78 78 . . . Note=Loss of acetylation. Partial loss of DNA-binding and transcriptional activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22367195;Dbxref=PMID:22367195 P10914 UniProtKB Mutagenesis 275 275 . . . Note=Some loss of sumoylation. Partial inhibition of acetylation and activity. Abolishes sumoylation%2C diminished ubiquitination%2C higher resistance to degradation%2C and increased apoptotic activity%3B when associated with R-299. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17942705;Dbxref=PMID:17942705 P10914 UniProtKB Mutagenesis 299 299 . . . Note=Large loss of sumoylation. Abolishes sumoylation%2C diminished ubiquitination%2C higher resistance to degradation%2C and increased apoptotic activity%3B when associated with R-275. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17942705;Dbxref=PMID:17942705 P10914 UniProtKB Sequence conflict 5 5 . . . Note=R->W;Ontology_term=ECO:0000305;evidence=ECO:0000305 P10914 UniProtKB Sequence conflict 34 35 . . . Note=FQ->LE;Ontology_term=ECO:0000305;evidence=ECO:0000305 P10914 UniProtKB Sequence conflict 220 220 . . . Note=T->I;Ontology_term=ECO:0000305;evidence=ECO:0000305